PMID: 12765506May 27, 2003Paper

Antiplatelet drugs

The Medical Journal of Australia
Graeme J Hankey, John W Eikelboom

Abstract

Antiplatelet drugs protect against myocardial infarction, stroke, cardiovascular death and other serious vascular events in patients with a history of previous vascular events or known risk factors for cardiovascular disease. Aspirin reduces the risk of serious vascular events in patients at high risk of such an event by about a quarter and is recommended as the first-line antiplatelet drug. Clopidogrel reduces the risk of serious vascular events among high-risk patients by about 10% compared with aspirin. It is as safe as aspirin, but much more expensive. It is an appropriate alternative to aspirin for long-term secondary prevention in patients who cannot tolerate aspirin, have experienced a recurrent vascular event while taking aspirin, or are at very high risk of a vascular event (>/= 20% per year). Addition of clopidogrel to aspirin reduces the risk of serious vascular events among patients with non-ST-segment elevation acute coronary syndromes by 20%, and patients undergoing percutaneous coronary intervention by 30%, compared with aspirin alone. Addition of a glycoprotein IIb/IIIa receptor antagonist to aspirin reduces the risk of vascular events among patients with non-ST-segment elevation acute coronary syndromes by 10% ...Continue Reading

References

Dec 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·B FarrellC Warlow
Oct 31, 1991·The New England Journal of Medicine·UNKNOWN Dutch TIA Trial Study GroupAnet van Latum
May 5, 1994·The New England Journal of Medicine·C Patrono
Mar 1, 1993·British Journal of Clinical Pharmacology·P J RoderickT W Meade
Dec 16, 1998·JAMA : the Journal of the American Medical Association·J HeM J Klag
Mar 4, 2000·Stroke; a Journal of Cerebral Circulation·UNKNOWN Abciximab in Ischemic Stroke Investigators
Mar 15, 2000·Circulation·E H Awtry, J Loscalzo
Jun 15, 2000·The New England Journal of Medicine·C L BennettH M Tsai
Oct 14, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·G HelftJ H Chesebro
Oct 21, 2000·The New England Journal of Medicine·D Sallière, K B Kassler-Taub
Nov 10, 2000·BMJ : British Medical Journal·S Derry, Y K Loke
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Aug 25, 2001·Lancet·S R MehtaUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
Jan 16, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
May 10, 2002·The New England Journal of Medicine·Michael S Lauer
Jun 7, 2002·The New England Journal of Medicine·Jean-Michel GaspozLee Goldman
Nov 19, 2002·JAMA : the Journal of the American Medical Association·Steven R SteinhublUNKNOWN CREDO Investigators. Clopidogrel for the Reduction of Events During Observation
Feb 7, 2003·Journal of the American College of Cardiology·Evangelia KarvouniJohn P A Ioannidis

❮ Previous
Next ❯

Citations

Jan 31, 2021·Journal of Cardiovascular Pharmacology and Therapeutics·Stavros DimitriadisAmer Harky
Jul 28, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Joseph Alcalay, Ronen Alkalay
Dec 22, 2004·Internal Medicine Journal·P A KublerM Frogley
Sep 18, 2010·Inflammatory Bowel Diseases·Naamah L ZitomerskyCameron C Trenor
Jun 28, 2005·Journal of Thrombosis and Haemostasis : JTH·P GaussemJ-N Fiessinger
Nov 27, 2008·Journal of Cardiovascular Pharmacology·Jamila K Adam, Wafaa N S Rmaih
Apr 17, 2008·European Journal of Anaesthesiology. Supplement·A Iorio
Jun 28, 2012·International Anesthesiology Clinics·Elizabeth VolzSameer J Khandhar
Nov 7, 2019·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I-K WangC Y Hsu
Aug 11, 2005·Der Anaesthesist·K BuhreW Buhre
May 27, 2004·International Journal of Clinical Practice·P A RinglebC Schwark
Sep 7, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Farrah J Mateen, Ashfaq Shuaib
Mar 30, 2005·Expert Opinion on Pharmacotherapy·Peter A RinglebPeter D Schellinger
May 15, 2013·Therapeutic Hypothermia and Temperature Management·Jason M MeunierGeorge J Shaw
Apr 20, 2005·Annals of Plastic Surgery·Alan MuskettWilliam C Lineaweaver
Aug 26, 2021·Annals of Medicine and Surgery·Seyed Muhammad Mehdi Ghaffari HamedaniSaeed Kargar Soliemanabad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.